17-alpha-hydroxyprogesterone has been researched along with Abnormalities, Urogenital in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abdalla, A; Dotters-Katz, SK; Hynes, JS; Manuck, TA; Schwartz, AR | 1 |
| Choi, JH; Kim, GH; Kim, YM; Ko, JM; Seo, GH; Yoo, HW | 1 |
2 other study(ies) available for 17-alpha-hydroxyprogesterone and Abnormalities, Urogenital
| Article | Year |
|---|---|
17-hydroxyprogesterone caproate for women with congenital uterine anomalies: does it impact the risk of recurrent preterm birth?
Topics: 17 alpha-Hydroxyprogesterone Caproate; 17-alpha-Hydroxyprogesterone; Female; Humans; Infant, Newborn; Pregnancy; Premature Birth; Urogenital Abnormalities; Uterus | 2021 |
A case of an infant suspected as IMAGE syndrome who were finally diagnosed with MIRAGE syndrome by targeted Mendelian exome sequencing.
Topics: 17-alpha-Hydroxyprogesterone; Adrenal Insufficiency; Adrenocorticotropic Hormone; Asian People; Cryptorchidism; Cyclin-Dependent Kinase Inhibitor p57; Exome Sequencing; Exons; Fetal Growth Retardation; Genital Diseases, Male; Humans; Hydrocortisone; Infant, Newborn; Intracellular Signaling Peptides and Proteins; Male; Mutation; Osteochondrodysplasias; Penis; Proteins; Renin; Urogenital Abnormalities | 2018 |